USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$28.86 USD
-0.53 (-1.80%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $28.86 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
USNA 28.86 -0.53(-1.80%)
Will USNA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for USNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USNA
Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now?
USANA Health (USNA) Upgraded to Buy: Here's Why
USNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
USNA or ZTS: Which Is the Better Value Stock Right Now?
Should Value Investors Buy Merck KGaA (MKKGY) Stock?
USANA Health Sciences (USNA) Q2 Earnings and Revenues Top Estimates
Other News for USNA
Insider Sell Alert: David Mulham Sells Shares of Usana Health Sciences Inc (USNA)
USANA Health Sciences: Hiya's Potential Is Showing
Usana Health Sciences Inc (USNA) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ...
Usana signals major compensation plan overhaul and product launches while repaying debt and achieving 11% sales growth
USANA Health Sciences, Inc. (USNA) Q2 2025 Earnings Call Transcript